Target N V Biotech Esperion Therapeutics, Inc. (ESPR) insider trading activity

Target N V Biotech is > 10% Shareholder of Esperion Therapeutics, Inc.. Currently has a direct ownership of 4.48 Million shares of ESPR, which is worth approximately $11.5 Million. The most recent transaction as insider was on May 24, 2021, when has been sold 100,000 shares (Common Stock) at a price of $20.22 per share, resulting in proceeds of $2,022,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.48M

0% 3M change

0% 12M change

Total Value Held $11.5 Million

TARGET N V BIOTECH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 24 2021	BUY Open market or private purchase	$2,022,000 $20.22 p/Share	100,000 Added 2.18%	4,477,964 Common Stock
May 19 2021	BUY Open market or private purchase	$4,074,000 $20.37 p/Share	200,000 Added 4.37%	4,377,964 Common Stock
May 06 2021	BUY Open market or private purchase	$1,645,600 $20.57 p/Share	80,000 Added 1.88%	4,177,964 Common Stock
May 05 2021	BUY Open market or private purchase	$3,003,000 $20.02 p/Share	150,000 Added 3.53%	4,097,964 Common Stock
Nov 03 2020	BUY Open market or private purchase	$5,062,000 $25.31 p/Share	200,000 Added 4.82%	3,947,964 Common Stock

Also insider at

MTEM

Molecular Templates, Inc. Healthcare

RDUS

Radius Health, Inc. Healthcare

> 10% Shareholder

MGNX

MACROGENICS INC Healthcare

> 10% Shareholder

TNV